Lessons from contemporary trials of cardiovascular prevention and rehabilitation: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 232, Issue , 2017, Pages 294-303

  van Halewijn, Gijs ^a,b   Deckers, Jaap ^a   Tay, Hung Yong ^b   van Domburg, Ron ^a   Kotseva, Kornelia ^b   Wood, David ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Angina pectoris; Atherosclerotic cardiovascular diseases; Cardiac rehabilitation; Cardiovascular prevention; Myocardial infarction; Peripheral arterial disease; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DRUG MONITORING; HEART INFARCTION; HEART PROTECTION; HEART REHABILITATION; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS; MORTALITY RATE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); CAUSE OF DEATH; GLOBAL HEALTH; MORTALITY; OUTCOME ASSESSMENT; PROCEDURES; SURVIVAL RATE; TRENDS;

CARDIAC REHABILITATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; GLOBAL HEALTH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 85009784185     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.12.125     Document Type: Article

References (43)

1. [1] Mendis, S., Puska, P., Norrving, B., Global Atlas on Cardiovascular Disease Prevention and Control. 2011, World Health Organization, Geneva, 164.
2. [2] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group P, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
3. [3] Heran, B.S., Chen, J.M., Ebrahim, S., Moxham, T., Oldridge, N., Rees, K., et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst. Rev., 7(7), 2011.
4. [4] Janssen, V., De Gucht, V., Dusseldorp, E., Maes, S., Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Prev. Cardiol., 2012 (2047487312462824).
5. [5] Brown, J.P.R., Clark, A.M., Dalal, H., Welch, K., Taylor, R.S., Effect of patient education in the management of coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. Eur. J. Prev. Cardiol., 2047487312449308, 2012.
6. [6] Whalley, B., Rees, K., Davies, P., Bennett, P., Ebrahim, S., Liu, Z., et al. Psychological interventions for coronary heart disease. Cochrane Database Syst. Rev., 8, 2011.
7. [7] Smith, S.C., Benjamin, E.J., Bonow, R.O., Braun, L.T., Creager, M.A., Franklin, B.A., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J. Am. Coll. Cardiol. 58:23 (2011), 2432–2446.
8. [8] O'Gara, P.T., 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (vol 127, pg e362, 2013). Circulation, 128(25), 2013, E481-E.
9. [9] Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E., Ganiats, T.G., Holmes, D.R., et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 64:24 (2014), e139–e228.
10. [10] Piepoli, M.F., Corra, U., Adamopoulos, S., Benzer, W., Bjarnason-Wehrens, B., Cupples, M., et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur. J. Prev. Cardiol. 21:6 (2014), 664–681.
11. [11] Fraker, T.D., Fihn, S.D., 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J. Am. Coll. Cardiol. 50:23 (2007), 2264–2274.
12. [12] Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., Keil, U., et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 16:2 (2009), 121–137.
13. [13] Cochrane Handbook for Systematic Reviews of Interventions. Available from www.cochrane-handbook.org2011.
14. [14] Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., Davey Smith, G., Multiple risk factor interventions for primary prevention of coronary heart disease. 2011, The Cochrane Library.
15. [15] The Nordic Cochrane Centre, Review Manager (RevMan). 2014, The Cochrane Collaboration Copenhagen.
16. [16] Anderson, L., Oldridge, N., Thompson, D.R., Zwisler, A.D., Rees, K., Martin, N., et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J. Am. Coll. Cardiol. 67:1 (2016), 1–12.
17. [17] Cole, J.A., Smith, S.M., Hart, N., Cupples, M.E., Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease. Cardiol. Res. Pract., 2011, 2010.
18. [18] de Melo Ghisi, G.L., Abdallah, F., Grace, S.L., Thomas, S., Oh, P., A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?. Patient Educ. Couns. 95:2 (2014), 160–174.
19. [19] Ter Hoeve, N., BMA, H., Stam, H.J., Van Domburg, R.T., Den Berg-Emons HJG, V., Current cardiac rehabilitation programmes are not sufficient for ACS patients to reach long-lasting changes in physical activity habits. A systematic review. Eur. Heart J., 34(Suppl. 1), 2013, P3644.
20. [20] West, R.R., Jones, D.A., Henderson, A.H., Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart 98:8 (2012), 637–644.
21. [21] Stewart, S., Chan, Y.K., Wong, C., Jennings, G., Scuffham, P., Esterman, A., et al. Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study. Eur. J. Heart Fail. 17:6 (2015), 620–630.
22. [22] Mosca, L., Christian, A.H., Mochari-Greenberger, H., Kligfield, P., Smith, S.C. Jr., A randomized clinical trial of secondary prevention among women hospitalized with coronary heart disease. J. Women's Health (Larchmt) 19:2 (2010), 195–202.
23. [23] Reid, R.D., Morrin, L.I., Beaton, L.J., Papadakis, S., Kocourek, J., McDonnell, L., et al. Randomized trial of an internet-based computer-tailored expert system for physical activity in patients with heart disease. Eur. J. Prev. Cardiol. 19:6 (2012), 1357–1364.
24. [24] Reid, R.D., Morrin, L.I., Higginson, L.A., Wielgosz, A., Blanchard, C., Beaton, L.J., et al. Motivational counselling for physical activity in patients with coronary artery disease not participating in cardiac rehabilitation. Eur. J. Prev. Cardiol. 19:2 (2012), 161–166.
25. [25] Brotons, C., Soriano, N., Moral, I., Rodrigo, M.P., Kloppe, P., Rodriguez, A.I., et al. Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study. Rev. Esp. Cardiol. 64:1 (2011), 13–20.
26. [26] Carrington, M.J., Chan, Y.K., Calderone, A., Scuffham, P.A., Esterman, A., Goldstein, S., et al. A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart study. Circ. Cardiovasc. Qual. Outcomes 6:4 (2013), 379–389.
27. [27] Moreno-Palanco, M.A., Ibanez-Sanz, P., Ciria-de Pablo, C., Pizarro-Portillo, A., Rodriguez-Salvanes, F., Suarez-Fernandez, C., Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS Study. Rev. Esp. Cardiol. 64:3 (2011), 179–185.
28. [28] Jorstad, H.T., von Birgelen, C., Alings, A.M., Liem, A., van Dantzig, J.M., Jaarsma, W., et al. Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart 99:19 (2013), 1421–1430.
29. [29] Krebs, J.D.V.W.K., Harding, S.A., Ward, M.A., Marra, B., Page, R.A., An intervention trial for patients with hyperglycaemia and acute coronary syndrome: How effective is lifestyle advice?. Prim. Care Cardiovasc. J. 6 (2013), 72–75.
30. [30] Cohen, A., Assyag, P., Boyer-Chatenet, L., Cohen-Solal, A., Perdrix, C., Dalichampt, M., et al. An education program for risk factor management after an acute coronary syndrome: a randomized clinical trial. JAMA Intern. Med. 174:1 (2014), 40–48.
31. [31] Janssen, V., De Gucht, V., van Exel, H., Maes, S., A self-regulation lifestyle program for post-cardiac rehabilitation patients has long-term effects on exercise adherence. J. Behav. Med. 37:2 (2014), 308–321.
32. [32] Saffi, M.A.L., Polanczyk, C.A., Rabelo-Silva, E.R., Lifestyle interventions reduce cardiovascular risk in patients with coronary artery disease: a randomized clinical trial. Eur. J. Cardiovasc. Nurs., 2014 (1474515113505396).
33. [33] He, Y.P., Lu, Z.G., Gu, Y.W., Pan, J.W., Gao, M.F., Wei, M., Impact of multifactor intensive intervention on self management, risk factor control and outcome of post percutaneous transluminal coronary intervention patients. Zhonghua Xin Xue Guan Bing Za Zhi 40:12 (2012), 1037–1040.
34. [34] Kuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355:9205 (2000), 675–687.
35. [35] Alter, D.A., Zagorski, B., Marzolini, S., Forhan, M., Oh, P.I., On-site programmatic attendance to cardiac rehabilitation and the healthy-adherer effect. Eur. J. Prev. Cardiol., 2014 (2047487314544084).
36. [36] Giannuzzi, P., Temporelli, P.L., Marchioli, R., Maggioni, A.P., Balestroni, G., Ceci, V., et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch. Intern. Med. 168:20 (2008), 2194–2204.
37. [37] Lawrence, M., Pringle, J., Kerr, S., Booth, J., Govan, L., Roberts, N.J., Multimodal secondary prevention behavioral interventions for TIA and stroke: a systematic review and meta-analysis. PLoS One, 10(3), 2015, e0120902.
38. [38] May, G.S., Eberlein, K.A., Furberg, C.D., Passamani, E.R., DeMets, D.L., Secondary prevention after myocardial infarction: a review of long-term trials. Prog. Cardiovasc. Dis. 24:4 (1982), 331–352.
39. [39] Oldridge, N.B., Guyatt, G.H., Fischer, M.E., Rimm, A.A., Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 260:7 (1988), 945–950.
40. [40] Wood, D.A., Kotseva, K., Connolly, S., Jennings, C., Mead, A., Jones, J., et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371:9629 (2008), 1999–2012.
41. [41] Jenni, J., Buckley John, P., Furze, G., Doherty, P., Linda, S., Connolly, S., et al. The BACPR standards and core components for cardiovascular prevention and rehabilitation 2012. 2012.
42. [42] Sandesara, P.B., Lambert, C.T., Gordon, N.F., Fletcher, G.F., Franklin, B.A., Wenger, N.K., et al. Cardiac rehabilitation and risk reduction: time to “rebrand and reinvigorate“. J. Am. Coll. Cardiol. 65:4 (2015), 389–395.
43. [43] Kotseva, K., Wood, D., De Bacquer, D., De Backer, G., Rydén, L., Jennings, C., et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur. J. Prev. Cardiol., 2047487315569401, 2015.